Axcess Global Sciences, LLC

57 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Mar 2037

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Nov 21, 2026
The maintenance fee for Mixed Salt Compositions for Maintaining or Restoring Electrolyte Balance While Producing Elevated and Sustained Ketosis (US 10,292,952) comes due Nov 21, 2026. Unpaid by May 21, 2027, it lapses early.
1 fee due Jan 4, 2027
The maintenance fee for Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use (US 11,690,817) comes due Jan 4, 2027. Unpaid by Jul 6, 2027, it lapses early.
1 fee due Mar 12, 2027
The maintenance fee for Administration of Beta-Hydroxybutyrate and Related Compounds in Humans for the Treatment And/Or Prevention of Respiratory Illnesses (US 11,752,119) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
2 fees due Apr 17 to 24, 2027 · next Apr 17
1 fee due May 7, 2027
The maintenance fee for Beta-Hydroxybutyric Acid Compositionsand Methods for Oral Delivery of Ketone Bodies (US 11,806,324) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
1 fee due Jun 24, 2027
The maintenance fee for Compositions and Methods for Delivering Cannabidiol and Ketone Bodies (US 10,512,615) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.
1 fee due Aug 13, 2027
The maintenance fee for Beta-hydroxybutyrate mixed salt compositions and methods of use (US 11,896,565) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
5 fees due Sep 17 to 24, 2027 · next Sep 17
4 fees due Oct 2 to 30, 2027 · next Oct 2

Which patents, and when each one lapses · Pro

Recent changes

1 of the patents on this record was granted since Aug 16, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 10,736,861	Mixed Salt Compositions for Producing Elevated and Sustained Ketosis In force Term ends Mar 9, 2037 · High confidence	In force	Term ends Mar 9, 2037	High confidence
US 10,973,786	R-Beta-Hydroxybutyrate, S-Beta-Hydroxybutyrate, and Rs-Beta-Hydroxybutyrate Mixed Salt Compositions In force Term ends Mar 9, 2037 · High confidence	In force	Term ends Mar 9, 2037	High confidence
US 10,973,792	Racemic Beta-Hydroxybutyrate Mixed Salt-Acid Compositions and Methods of Use In force Term ends Mar 9, 2037 · High confidence	In force	Term ends Mar 9, 2037	High confidence
US 11,020,362	Beta-Hydroxybutyrate Mixed Salt Compositions and Methods of Use In force Term ends Mar 9, 2037 · High confidence	In force	Term ends Mar 9, 2037	High confidence
US 11,103,470	Non-Racemic Beta-Hydroxybutyrate Compounds and Compositions Enriched with the R-Enantiomer and Methods of Use In force Term ends Mar 9, 2037 · High confidence	In force	Term ends Mar 9, 2037	High confidence
US 11,241,401	Enantiomerically Pure R-Beta-Hydroxybutyrate Mixed Salt-Acid Compositions In force Term ends Mar 9, 2037 · High confidence	In force	Term ends Mar 9, 2037	High confidence
US 11,241,403	Beta-hydroxybutyrate mixed salt compositions and methods of use In force Ends no later than Mar 9, 2037 · From the USPTO record	In force	Ends no later than Mar 9, 2037	From the USPTO record
US 11,806,324	Beta-Hydroxybutyric Acid Compositionsand Methods for Oral Delivery of Ketone Bodies In force Term ends Mar 9, 2037 · High confidence	In force	Term ends Mar 9, 2037	High confidence
US 11,944,598	Compositions Containing S-Beta-Hydroxybutyrate or Non-Racemic Mixtures Enriched with the S-Enatiomer In force Term ends Mar 9, 2037 · High confidence	In force	Term ends Mar 9, 2037	High confidence
US 12,109,182	Administration of R-Beta-Hydroxybutyrate and Related Compounds in Humans In force Term ends Mar 9, 2037 · High confidence	In force	Term ends Mar 9, 2037	High confidence

10 of 57 patents shown.

Pro members see all 57.

Pro members: see all 57 patents

Also on record, not counted in the 57: 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

9 pending · 1 no status recorded

List them